US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 20.940
  • +0.740+3.66%
Close Jun 7 16:00 ET
  • 20.490
  • -0.450-2.15%
Post 18:46 ET
984.95MMarket Cap-12310P/E (TTM)

About Enliven Therapeutics Company

Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO.

Company Profile

SymbolELVN
Company NameEnliven Therapeutics
Listing DateMar 12, 2020
Founded2019
CEOMr. Sam Kintz, M.B.A.
MarketNASDAQ
Employees46
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6200 Lookout Road
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-720-647-8519
Websitehttp://www.enliventherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Sam Kintz, M.B.A.
  • President, Chief Executive Officer and Director
  • 8.28M
  • Dr. Joseph P. Lyssikatos, PhD
  • Chief Scientific Officer and Director
  • 4.01M
  • Dr. Anish Patel, Pharm.D.
  • Chief Operating Officer
  • --
  • Dr. Helen Collins, M.D.
  • Chief Medical Officer
  • 4.06M
  • Benjamin Hohl
  • Head of Corporate Development, Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Richard Heyman, PhD
  • Chairman of the Board
  • 664.11K
  • Dr. Lori Anne Kunkel, M.D.
  • Director
  • --
  • Dr. Rahul D. Ballal, PhD
  • Director
  • 1.87M
  • Rishi Gupta, J.D.
  • Independent Director
  • 538.26K
  • Dr. Mika Derynck, M.D.
  • Independent Director
  • 541.48K
  • Jacob Bauer, M.B.A.
  • Independent Director
  • 551.21K
  • Dr. Andrew Phillips, PhD
  • Independent Director
  • 542.95K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg